SEC 13F Intelligence

Handelsbanken Fonder AB / LLY

Handelsbanken Fonder AB’s Eli Lilly & Co Position

Does Handelsbanken Fonder AB own Eli Lilly & Co (LLY)? Yes — 708.5K shares worth $652M (+2.17% of its 13F portfolio) as of Q1 2026, down from 764.8K shares the prior filed quarter.

Position Value
$652M
Q1 2026
Shares
708.5K
% of Portfolio
+2.17%
Quarters Held
29
currently held

Position History LLY

Reported value by quarter
Q1 ’19: $76MQ1 ’19Q2 ’19: $87MQ3 ’19: $99MQ4 ’19: $120MQ1 ’20: $112MQ1 ’20Q2 ’20: $302MQ3 ’20: $147MQ4 ’20: $176MQ1 ’21: $186MQ1 ’21Q2 ’21: $234MQ3 ’21: $242MQ4 ’21: $288MQ1 ’22: $261MQ1 ’22Q2 ’22: $277MQ3 ’22: $267MQ4 ’22: $311MQ1 ’23: $311MQ1 ’23Q2 ’23: $433MQ3 ’23: $457MQ4 ’23: $488MQ1 ’24: $619MQ1 ’24Q2 ’24: $686MQ3 ’24: $680MQ4 ’24: $591MQ1 ’25: $606MQ1 ’25Q2 ’25: $592MQ3 ’25: $650MQ4 ’25: $822MQ1 ’26: $652MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026708.5K$652M+2.17%
Q4 2025764.8K$822M+2.48%
Q3 2025852.5K$650M+2.07%
Q2 2025759.8K$592M+2.10%
Q1 2025733.9K$606M+2.50%
Q4 2024765.0K$591M+2.25%
Q3 2024767.0K$680M+2.69%
Q2 2024758.1K$686M+2.98%
Q1 2024795.6K$619M+2.66%
Q4 2023837.2K$488M+2.37%
Q3 2023850.2K$457M+2.56%
Q2 2023923.9K$433M+2.32%
Q1 2023906.4K$311M+1.80%
Q4 2022850.0K$311M+1.95%
Q3 2022826.4K$267M+1.79%
Q2 2022854.4K$277M+1.80%
Q1 2022912.3K$261M+1.46%
Q4 20211.04M$288M+1.42%
Q3 20211.05M$242M+1.27%
Q2 20211.02M$234M+1.22%
Q1 2021995.8K$186M+1.06%
Q4 20201.04M$176M+1.07%
Q3 2020991.2K$147M+1.07%
Q2 20201.84M$302M+1.28%
Q1 2020808.5K$112M+2.41%
Q4 2019911.5K$120M+2.07%
Q3 2019886.5K$99M+2.00%
Q2 2019786.5K$87M+1.61%
Q1 2019589.4K$76M+1.48%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Handelsbanken Fonder AB’s full portfolio or all institutional holders of LLY.